Revolution Medicines (RVMD) Revenue & Revenue Breakdown
Revolution Medicines Revenue Highlights
Latest Revenue (Y)
$11.58M
Main Segment (Y)
Collaboration Revenue Member
Revolution Medicines Revenue by Period
Revolution Medicines Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $11.58M | -67.27% |
2022-12-31 | $35.38M | 20.38% |
2021-12-31 | $29.39M | -31.62% |
2020-12-31 | $42.98M | -14.10% |
2019-12-31 | $50.04M | 148.16% |
2018-12-31 | $20.16M | 100.00% |
2017-12-31 | - | - |
Revolution Medicines Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $742.00K | 100.00% |
2023-09-30 | - | -100.00% |
2023-06-30 | $3.82M | -45.48% |
2023-03-31 | $7.01M | -54.25% |
2022-12-31 | $15.33M | 356.79% |
2022-09-30 | $3.36M | -63.19% |
2022-06-30 | $9.12M | 20.30% |
2022-03-31 | $7.58M | -19.89% |
2021-12-31 | $9.46M | 759.22% |
2021-09-30 | $1.10M | -87.34% |
2021-06-30 | $8.70M | -14.14% |
2021-03-31 | $10.13M | 15.77% |
2020-12-31 | $8.75M | -30.88% |
2020-09-30 | $12.66M | 26.29% |
2020-06-30 | $10.03M | -13.17% |
2020-03-31 | $11.55M | -4.48% |
2019-12-31 | $12.09M | -3.34% |
2019-09-30 | $12.51M | 1.83% |
2019-06-30 | $12.28M | -6.72% |
2019-03-31 | $13.17M | 27.24% |
2018-12-31 | $10.35M | - |
Revolution Medicines Revenue Breakdown
Revolution Medicines Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 22 | Dec 21 | Dec 20 |
---|---|---|---|
Collaboration Revenue Member | $35.38M | $29.39M | - |
Collaboration Revenue Related Party | - | - | $42.98M |
Latest
Quarterly Revenue by Product
Product/Service | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Collaboration Revenue Member | $7.01M | $15.33M | $3.36M | $9.12M | $9.46M | - | - | - | - | - | - | - | - |
Collaboration Revenue | - | - | - | - | $7.58M | $1.10M | $8.70M | $10.13M | - | - | - | - | - |
Collaboration Revenue Related Party | - | - | - | - | - | - | - | - | - | $8.75M | $12.66M | $10.03M | $11.55M |
Latest
Revolution Medicines Revenue Breakdown by Country
Quarterly Revenue by Country
Country | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Collaboration Revenue Member | $7.01M | $15.33M | $3.36M | $9.12M | $9.46M | - | - | - | - | - | - | - | - |
Collaboration Revenue | - | - | - | - | $7.58M | $1.10M | $8.70M | $10.13M | - | - | - | - | - |
Collaboration Revenue Related Party | - | - | - | - | - | - | - | - | - | $8.75M | $12.66M | $10.03M | $11.55M |
Latest
Revolution Medicines Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
BPMC | Blueprint Medicines | $249.38M | $128.18M |
KYMR | Kymera Therapeutics | $78.59M | $3.74M |
NRIX | Nurix Therapeutics | $76.99M | $12.59M |
PTGX | Protagonist Therapeutics | $60.00M | $4.67M |
AGIO | Agios Pharmaceuticals | $26.82M | $8.96M |
RVMD | Revolution Medicines | $11.58M | - |
RNA | Avidity Biosciences | $9.56M | $2.04M |
STOK | Stoke Therapeutics | $8.78M | $4.89M |
BDTX | Black Diamond Therapeutics | - | - |
CCCC | C4 Therapeutics | - | - |
PASG | Passage Bio | - | - |
SANA | Sana Bio | - | - |
GLUE | Monte Rosa Therapeutics | - | $4.70M |
AKRO | Akero Therapeutics | - | - |